O câncer de esôfago (CE) é um tumor que surge nas células que revestem a parte interna do esôfago e pode ser dividido em dois tipos principais: o câncer de células escamosas do esôfago (CECE) e o adenocarcinoma de esôfago (ADE).
Introdução
O que você precisa saber de cara
O carcinoma do esôfago é um tipo de tumor que se forma nas células que revestem o interior do esôfago, canal responsável por levar o alimento da boca até o estômago. A pessoa com a condição pode sentir sintomas como queimação por refluxo gastroesofágico, dor no peito, tosse persistente e náuseas. O diagnóstico é confirmado pela identificação das células tumorais na parede esofágica, podendo envolver subtipos como o adenocarcinoma ou o carcinoma escamoso. No Brasil, a condição não está incluída na lista oficial de PCDTs de doenças raras do SUS, devendo o paciente buscar apoio e acompanhamento pela rede oncológica de saúde.
O câncer de esôfago (CE) é um tumor que surge nas células que revestem a parte interna do esôfago e pode ser dividido em dois tipos principais: o câncer de células escamosas do esôfago (CECE) e o adenocarcinoma de esôfago (ADE).
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 2 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 11 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
5 genes identificados com associação a esta condição.
Glioma
Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.
Esophageal cancer
A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage.
Hereditary non-polyposis colorectal cancer 6
An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
Variantes genéticas (ClinVar)
991 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 4 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
44 vias biológicas associadas aos genes desta condição.
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Carcinoma do esôfago
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
Com ensaio aberto em 10 países. O ponto verde marca onde há vaga agora.
🟢 Recrutando agora
26 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
107 ensaios clínicos encontrados, 39 ativos.
Publicações mais relevantes
Neuroendocrine carcinoma of esophagus: systematic review and meta-analysis of case series.
Neuroendocrine carcinoma of the esophagus is a highly aggressive and rare type of cancer, making diagnosis and treatment challenging for clinicians. The current guidelines provide conflicting recommendations, and no standardized treatment protocol is available. We aim to deliver a systematic review of esophageal neuroendocrine carcinoma, including patient characteristics, treatment options, and prognostic factors. PubMed, Web of Science, Scopus, and Embase were searched up to May 2025 to retrieve the relevant studies containing at least 5 cases that reported treatment details, survival outcomes, or patient characteristics. Meta-analysis was conducted using a random-effects model for prognostic factors reported in at least three studies. We calculated survival information using the Kaplan-Meier method and estimated the median 1, 3, and 5-year survival rates in studies with available individual data that did not directly report the survival outcomes. Overall, 24 articles with 1618 cases were included. The median overall survival of patients was 22.5 months, with median 1-, 3-, and 5-year survival rates of 76%, 47%, and 34%, respectively. Distant metastasis (HR, 2.68; 95% CI: 2.10 to 3.41; P < .01) and lymph node involvement (HR, 1.44; 95% CI: 1.04 to 1.99; P = .02) were significantly associated with poor prognosis. Surgery in selected cases improved the survival outcomes with an HR of 0.36 (95% CI, 0.28 to 0.46; P = < .01). The current study demonstrates that distant metastasis and lymph node involvement are significant predictors of poor prognosis in esophageal neuroendocrine carcinoma. Survival outcomes were comparable between patients with resectable tumors undergoing surgery and those receiving definitive chemoradiotherapy, both of which outperformed chemotherapy alone or no treatment. While adjuvant therapy may improve survival in node-positive cases post-surgery, this evidence remains limited by small sample sizes in existing studies. Further large-scale, prospective studies are needed to validate optimal treatment strategies, particularly the role of multimodal therapy in advanced disease.
Carcinoma of Esophagus.
Carcinoma of esophagus is one of the most common cancer worldwide, but its epidemiology is changing. Squamous cell carcinoma is declining in the East, but adenocarcinoma is rising in the West, probably related to the pandemic of obesity and changing lifestyle. Screening of esophageal cancer (both endoscopic and nonendoscopic methods) is recommended in patients suffering from long-term acid reflux symptoms associated with high-risk factors and surveillance in patients with Barrett's esophagus. Endoscopy with virtual chromoendoscopy, endoscopic ultrasound, and CT scan is essential for diagnosis and staging of the disease. Endoscopic therapy can be used to treat early diseases. Surgery remains a mainstay treatment. Multimodality treatment strategies involving combinations of chemotherapy, radiotherapy, and more recently immunotherapy and target therapies are gaining momentum.
Calmodulin-Like Protein 5 (CALML5) Expression in Squamous Cell Carcinoma of Esophagus and Oropharynx.
Squamous cell carcinoma (SCC), a common malignancy affecting the skin, vagina, uterine cervix, anus, larynx, and upper digestive tract, is characterized by significant disruption of cell-cell adhesion in stratified squamous epithelium during tumorigenesis, progression, and metastasis. CALML5, a stratified epithelial-specific protein linked to desmosomal junctions, plays a key role in cell adhesion and is notably downregulated in human papillomavirus (HPV)-associated cervical SCC. Esophageal and pharyngeal cancers, commonly with a squamous cell phenotype, have distinct etiologies: oropharyngeal carcinoma is strongly associated with HPV, whereas esophageal carcinoma is linked to environmental factors such as smoking, alcohol, and diet. To investigate the role of CALML5 in these cancers, we performed immunohistochemical analyses on clinical samples and explored its regulatory mechanisms using in vitro studies with human esophageal SCC cell lines. Our findings revealed that CALML5 expression is suppressed in early-stage esophageal SCC but reactivated at invasive sites in well to moderately differentiated SCC undergoing keratinization. In specialized SCC with sarcomatoid component, CALML5 reactivation occurred alongside aberrant KLF4 expression, highlighting its context-dependent role in tumor progression. Conversely, while HPV-unrelated oropharyngeal SCC exhibited patterns similar to esophageal SCC, HPV-related oropharyngeal SCC consistently showed suppressed CALML5 expression due to impaired KLF4 nuclear translocation. These results suggest that CALML5 functions as a tumor suppressor in HPV-associated cervical SCC but may be reactivated in non-HPV-associated invasive SCC, emphasizing its complex role in SCC pathogenesis and the need for careful interpretation of its expression in clinical contexts.
Demographic analysis of survival trends in squamous cell carcinoma of the upper 1/3 of the esophagus: a population-based study.
Esophageal malignancies, constituting 3% of global cancers, pose significant health challenges with poor survival rates. Squamous Cell Carcinoma (SCC) and Adenocarcinoma (AC) are predominant subtypes, with shifting incidences globally. This analysis will focus primarily on the demographics of survival trends for Squamous cell carcinoma of esophagus (SCCE). This retrospective study, utilizing the SEER database, examined demographic factors influencing survival trends in SCC of the upper esophagus. Variables included age, sex, race, income, and rurality. Statistical analyses included chi-square tests and multivariable models, specifically logistic regression and conditional inference tree models. A total of 2821 patients were included in this study. Demographic disparities were evident with race (p < 0.001), age (p = 0.002), and sex (p = 0.048) significantly impacting survival when holding other variables constant, with Non-Hispanic Black individuals exhibiting the greatest odds of mortality compared to other racial groups. Median household income (p = 0.344) and Rural-Urban Continuum (p = 0.100) were not significantly associated with improved survival rates when controlling for other demographics. Our findings align with previous research on sex-based survival disparities and racial variations in SCCE incidence and outcomes. Socioeconomic and biological factors contribute to these disparities, highlighting the need for tailored interventions and equitable healthcare access. Understanding demographic determinants in SCCE survival is crucial for personalized treatment and policy reforms to address disparities. Future research should focus on prospective, diverse cohorts to further elucidate these complex interactions and improve esophageal SCCE management and outcomes.
Management of Carcinoma of Esophagus in Old Patient with Panchagavya Therapy as a Palliative Care-A Case Report.
Esophageal cancer is a male-dominant, aggressive malignancy with a five-year survival rate of 15%-20%, predominantly affecting developed nations. Esophageal squamous cell carcinoma (ESCC) is the most common subtype. This case study involves a 70-year-old man with ESCC, who was suffering from difficulty swallowing, inability to burp, constant nausea, and occasional trouble swallowing water for two months. He was successfully treated with Panchagavya Chikitsa, which included Panchagavya Ghrita, Gomutra Arka, Kwath of Amla-Yashtimadhu-Shatpushpa, Haritaki Churna, Haridra Ghanvati, and Vibhitaki Avaleha, along with Nasya, Nabhipurana with Panchagavya Ghrita, and Matra Vasti with Tila Taila over six months. Significant symptom improvement was observed, attributed to the Rasayana (rejuvenative), Balya (strengthening), and Jeevaniya (vitality-enhancing) properties of the treatments. These properties inhibit cancer growth, nourish tissues, and restore balance due to their antioxidant effects. Panchagavya formulations showed promising results without adverse effects, highlighting their efficacy in improving the quality of life for this geriatric patient with ESCC.
Publicações recentes
Neuroendocrine carcinoma of esophagus: systematic review and meta-analysis of case series.
🥉 Relato de casoCalmodulin-Like Protein 5 (CALML5) Expression in Squamous Cell Carcinoma of Esophagus and Oropharynx.
Management of Carcinoma of Esophagus in Old Patient with Panchagavya Therapy as a Palliative Care-A Case Report.
📖 RevisãoDemographic analysis of survival trends in squamous cell carcinoma of the upper 1/3 of the esophagus: a population-based study.
📚 EuropePMC170 artigos no totalmostrando 74
Neuroendocrine carcinoma of esophagus: systematic review and meta-analysis of case series.
BMC gastroenterologyCalmodulin-Like Protein 5 (CALML5) Expression in Squamous Cell Carcinoma of Esophagus and Oropharynx.
Acta histochemica et cytochemicaManagement of Carcinoma of Esophagus in Old Patient with Panchagavya Therapy as a Palliative Care-A Case Report.
Journal of pharmacy & bioallied sciencesDemographic analysis of survival trends in squamous cell carcinoma of the upper 1/3 of the esophagus: a population-based study.
Diseases of the esophagus : official journal of the International Society for Diseases of the EsophagusA case report of metastatic esophageal squamous cell carcinoma during pregnancy.
SAGE open medical case reportsSpatiotemporal Distribution, Time to Treatment Outcome Clustering and Determinants of Esophageal Cancer in Ethiopia, a Scoping Study.
Cancer control : journal of the Moffitt Cancer CenterAdenoid Cystic Carcinoma of Esophagus with Lung Metastasis: Case Report.
Annali italiani di chirurgiaDosimetric comparison of 3DCRT and IMRT in radical chemoradiotherapy of squamous cell carcinoma esophagus.
Journal of cancer research and therapeuticsSmall Cell Oesophageal Carcinoma: A Retrospective Case Series From a UK Tertiary Centre and a Review of the Literature.
CureusThe role of surgery or definitive chemoradiotherapy in management of localized squamous cell carcinoma of esophagus - What is the verdict?
Critical reviews in oncology/hematologyUndifferentiated Carcinoma of Esophagus with SMARCA4 Deletion Expressing Synaptophysin: A Potential Diagnostic Pitfall.
International journal of surgical pathologyDistal-continual colon interposition for esophageal reconstruction after esophagectomy: Two case reports.
Frontiers in surgeryCorrosive induced early carcinoma of esophagus after 55 years: Resection by endoscopic submucosal dissection.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the LiverNeuroendocrine Carcinoma of the Esophagus With Liver Metastasis: A Case Report.
CureusFactors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction.
Journal of surgical oncologyPrevalence, Distribution, and Histopathological Features of Malignant Tumors Reported at Tertiary Level in Afghanistan: A 3-Year Study.
Cancer management and research[Analysis of Clinicopathological Characteristics of 88 Cases with Secondary Neoplasms of the Thyroid Gland].
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science editionLarge-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome.
CureusEsophageal Neuroendocrine Carcinoma: A Case Report and Literature Review.
CureusDeleterious mutations in esophageal carcinoma cuniculatum detected by next generation sequencing.
International journal of clinical and experimental pathologyA Rare Case of Primary Small Cell Carcinoma of Esophagus.
CureusExpression of CD44 and CD133 stem cell markers in squamous cell carcinoma of esophagus.
Indian journal of pathology & microbiologyPrognostic Significance of the Microbiome and Stromal Cells Phenotype in Esophagus Squamous Cell Carcinoma.
BiomedicinesAssociation between oral microflora and gastrointestinal tumors (Review).
Oncology reportsA rare case of lung abscess due to esophageo-pulmonary fistula in asymptomatic carcinoma of esophagus.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del toraceEsophageal leiomyoma and simultaneous overlying squamous cell carcinoma: a case report and review of the literature.
BMC surgeryComparison of treatment response assessed by 18F-FDG PET/CT with the histopathological response using tumor regression grading on surgically resected specimen following neoadjuvant chemotherapy in squamous cell carcinoma of esophagus.
Nuclear medicine communicationsA network meta-analysis for neoadjuvant and adjuvant treatments for resectable squamous cell carcinoma of esophagus.
Scientific reportsThe First Literature Case Report: Synchronous Squamous Cell Carcinoma of Esophagus and Adenocarcinoma of Gallbladder.
Journal of gastrointestinal cancerInfluence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro-esophageal junction from a tertiary cancer care center in India.
Journal of surgical oncologyNomogram based on nutritional and inflammatory indicators for survival prediction of small cell carcinoma of the esophagus.
Nutrition (Burbank, Los Angeles County, Calif.)Fungal profile and antifungal susceptibility pattern of candidiasis in esophageal cancer patients.
Journal of cancer research and therapeuticsModified reverse-puncture anastomotic technique vs. traditional technique for total minimally invasive Ivor-Lewis esophagectomy.
World journal of surgical oncologyPersistent cough: An unexpected diagnosis.
Journal of family medicine and primary care[A Case of Small Cell Carcinoma of Esophagus in Which Long-Term Survival Was Achieved with Multimodal Treatment].
Gan to kagaku ryoho. Cancer & chemotherapyPlummer-Vinson syndrome: A decade's experience of 132 cases from a single center.
Journal of gastroenterology and hepatologyClinical profile of patients presenting with dysphagia - an experience from a tertiary care center in North India.
JGH open : an open access journal of gastroenterology and hepatologySignificance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction.
Annals of surgical oncologyLong-term treatment results and prognostic factors of synchronous and metachronous squamous cell carcinoma of head and neck and esophagus.
Translational cancer researchPrognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
Annals of surgeryRadiotherapy for small cell carcinoma of the esophagus: outcomes and prognostic factors from a retrospective study.
Radiation oncology (London, England)Gastric Conduit Perforation: A Late Fatal Complication after Esophagectomy.
CureusUGT2B17 and miR-224 contribute to hormone dependency trends in adenocarcinoma and squamous cell carcinoma of esophagus.
Bioscience reports[Neoendocrine carcinoma of the esophagus: report of a case].
Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del PeruExpression and Significance of TRIM 28 in Squamous Carcinoma of Esophagus.
Pathology oncology research : PORConsidering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker.
Personalized medicineExpression and significance of ASPP2 in squamous carcinoma of esophagus.
The Kaohsiung journal of medical sciencesEndoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review.
Critical reviews in oncology/hematologyEndoscopic submucosal dissection in a patient with esophageal adenoid cystic carcinoma.
World journal of gastroenterologyPneumatic Balloon Dilatation for Achalasia Cardia; Early & late results, a single center study.
Pakistan journal of medical sciencesThe impact of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced squamous cell carcinoma of esophagus.
Journal of the Chinese Medical Association : JCMALymphoepithelioma-Like Carcinoma of the Esophagus: A Rare Tumor.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSPEndoscopic diagnosis and management of early squamous cell carcinoma of esophagus.
Journal of thoracic diseaseCorrosive-Induced Carcinoma of Esophagus: Esophagographic and CT Findings.
AJR. American journal of roentgenologySOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncMultiple Meningocerebral Metastasis and Extensive Skull Metastasis from Squamous Cell Carcinoma of Esophagus: A Case Report and Review of Literature.
Brain tumor research and treatmentRobotic-assisted minimally invasive esophagectomy for treatment of esophageal carcinoma.
Journal of robotic surgeryComplete response to abdominal bulky lymph node recurrence in an esophageal cancer patient treated with S-1 monotherapy: A case report.
Oncology lettersAdjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients: A Retrospective Cohort Study of Multicenter Clinical Outcomes.
MedicineIncidence of esophageal cancer in Sri Lanka: Analysis of cancer registry data and comparison with other South Asian populations.
Asia-Pacific journal of clinical oncologySquamous cell and neuroendocrine carcinoma of esophagus: Collision versus composite tumor: A case report and review of literature.
Indian journal of cancerMiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineMucoepidermoid carcinoma of esophagus combined with squamous carcinoma of lung: A case report and literature review.
Journal of cancer research and therapeuticsGenotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a case-control study from Kashmir, India.
Diseases of the esophagus : official journal of the International Society for Diseases of the EsophagusAdenocarcinoma of Cervical Esophagus Arising in the Barrett's Mucosa.
Indian journal of surgical oncologyPerioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus: A Phase III Randomized Trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung CancerLeu432Val Polymorphism of CYP1B1 is Not Associated with Squamous Cell Carcinoma of Esophagus--a Case-Control Study from Kashmir, India.
Asian Pacific journal of cancer prevention : APJCPPrimary Small Cell Carcinoma of The Esophagus - An Eight Year Retrospective Study.
Journal of clinical and diagnostic research : JCDRDiagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus.
Diagnostic pathologyOutcomes of patients with squamous cell carcinoma of esophagus who did not receive surgical resection after neoadjuvant radiochemotherapy.
TumoriOral manifestations of plummer-vinson syndrome: a classic report with literature review.
Journal of international oral health : JIOHPalliative radiotherapy in esophageal cancer.
The Indian journal of surgery[Clinicopathologic observation of adenoid cystic carcinoma of esophagus].
Zhonghua bing li xue za zhi = Chinese journal of pathologyImmune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine.
International journal of oncologyAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Carcinoma do esôfago.
É de uma associação que acompanha esta doença? Fale com a gente →
Doença com base genética
Um médico geneticista pode ajudar no diagnóstico de Carcinoma do esôfago e no aconselhamento genético da família.
Doenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Perguntas frequentes
O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu
É um tumor maligno que afeta as células da camada interna do esôfago. Pode se dividir principalmente em câncer de células escamosas (CECE) e adenocarcinoma de esôfago (ADE).
Referências
Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete
5 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Citar este verbete
Raras. (s.d.). Carcinoma do esôfago. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/carcinoma-do-esofago
Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
Carcinoma do esôfago
📋 Origem dos dados
Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.
- Doença rara (ontologia)
- fonte: Orphanet
- Identificador unificado
- fonte: MONDO
- NIH/GARD
- fonte: GARD (NIH)
- Dado público estruturado
- fonte: Wikidata
- Ensaios clínicos
- fonte: ClinicalTrials.gov